Global Owren's Disorder Market, By Causes (Disseminated Intravascular Coagulation (DIC), Cirrhosis, Secondary Fibrinolysis, Lupus), Symptoms (Abnormal Bleeding After Giving Birth, Abnormal Bleeding Under The Skin, Umbilical Cord Bleeding At Birth, Nosebleeds, Bleeding Gums, Easy Bruising, Heavy Or Prolonged Menstrual Periods), Diagnosis (Factor Assays, Factor V Assay, Inhibitor Tests), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Owren's Disorder Market Analysis and Size
The global owren's disorder market is expected to witness significant growth during the forecast period. Rise in the government awareness programs about the disease will raise the market growth. In addition to this, increase in the population, rise in the healthcare affordability in the U.S. and rise in the knowledge and awareness amongst the people are some of the key factors among others boosting the owren's disorder market growth. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global owren's disorder market in the forecast period 2022-2029. The expected CAGR of global owren's disorder market is tend to be around 6% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Owren's Disorder Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Causes (Disseminated Intravascular Coagulation (DIC), Cirrhosis, Secondary Fibrinolysis, Lupus), Symptoms (Abnormal Bleeding After Giving Birth, Abnormal Bleeding Under The Skin, Umbilical Cord Bleeding At Birth, Nosebleeds, Bleeding Gums, Easy Bruising, Heavy Or Prolonged Menstrual Periods), Diagnosis (Factor Assays, Factor V Assay, Inhibitor Tests), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc.(U.S.), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), Mitsubishi Chemical Group Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany.), AstraZeneca (India), Zimmer Biomet (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Crystal Genomics Inc (South Korea), ABIOGEN PHARMA S.p.A (Italy)
|
|
Market Opportunities
|
|
Market Definition
Owren’s disease is also termed as Factor V or parahemophilia. It is a type of rare bleeding disorder that results in poor clotting after an injury or surgery. Factor V deficiency should not be mixed with factor V Leiden mutation, which is a much more common condition that leads to severe blood clotting.
Global Owren's Disorder Market Dynamics
Drivers
- Rise in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of R&D activities. This will benefit the global owren’s disorder market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding R&D initiatives.
Opportunities
- Increased Demands of Diagnostic Tests
Different types of diagnostic procedures are helping to create opportunities of the global owren’s disorder market. Tests such as defective lymphocyte apoptosis, lymph node pathology and many such other tests are available today with regard to this. All these factors are also contributing in the growth of the market.
- Increasing Demand for Retail Pharmacies
Increase in the number of drugs used for global owren’s disorder market being delivered through retail pharmacies and the increase in the number of retail pharmacies in developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform these treatments could curb the growth of the global owren's disorder market over a forecast period.
- Development of Complications
Many a times, patients aid in the treatment process themselves and these creates complications. Treatment without proper consultation with the doctor is dangerous and results in negative impact on the patients. All these factors restrict the growth of the market.
This global owren's disorder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global owren's disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Owren's Disorder Market Scope
The global owren's disorder market is segmented on the basis of causes, symptoms, diagnosis, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Causes
- Disseminated Intravascular Coagulation (DIC)
- Cirrhosis
- Secondary Fibrinolysis
- Lupus
Symptoms
- Abnormal Bleeding After Giving Birth
- Abnormal Bleeding Under The Skin
- Umbilical Cord Bleeding At Birth
- Nosebleeds
- Bleeding Gums
- Easy Bruising
- Heavy Or Prolonged Menstrual Periods
Diagnosis
- Factor Assays
- Factor V Assay
- Inhibitor Tests
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Owren's Disorder Market Regional Analysis/Insights
The global owren's disorder market is analysed and market size insights and trends are provided by causes, symptoms, diagnosis, distribution channel and end-user as referenced above.
The major countries covered in the global owren's disorder market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for global owren's disorder market throughout the forecasted period due to huge patient population, and rise in the presence of huge opportunity in the market in this region.
North America dominates the market due to continuous change in the lifestyle and increasing healthcare expenditure, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for R&D in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Owren's Disorder Market Share Analysis
The global owren's disorder market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global owren's disorder market
Key players operating in the global owren's disorder market include:
- Pfizer Inc.(U.S.)
- Merck KGaA (Germany)
- Sanofi (France)
- Biocare Medical, LLC (U.S.)
- Lilly (U.S.)
- Teva Pharmaceutical Industries (Israel)
- Mitsubishi Chemical Group Corporation (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- GlaxoSmithKline plc. (U.K.)
- Bayer AG (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Lilly (U.S.)
- AstraZeneca (India)
- Zimmer Biomet (Poland)
- DAIICHI SANKYO COMPANY, LIMITED (Japan)
- Crystal Genomics Inc (South Korea)
- ABIOGEN PHARMA S.p.A (Italy)
SKU-